We’re There When You Need Us: A 24-7 Emergency Care Hotline for the AS Community
Explore our 24-7 emergency care hotline for Angelman Syndrome (AS), providing standardized, expert care for children with AS. Join us in revolutionizing rare disease treatment.
Update on the UK Natural History Study and Wearable Devices
Explore the latest updates on the UK Natural History Study and the role of wearable devices in medical research. Discover the importance of these studies and the challenges faced in conducting them.
Update on Angelman Syndrome Human iPSC Biorepository Project and the Angelman Syndrome Large Deletion Mouse Model
Advancing understanding and treatment of Angelman Syndrome through iPSC cell lines and mouse models. Valuable resources for researchers.
Translational Research in a Large Animal Model of Angelman Syndrome
Explore the development and importance of a pig model for Angelman Syndrome research. Discover how this model aids in understanding the condition’s pathophysiology and testing potential therapies.
The Creation of a Robust Infrastructure Including Molecular, Neurobehavior, and Biomarker Testing for Pre-Clinical Drug Evaluation in Angelman Syndrome
Explore the creation of a robust infrastructure for pre-clinical drug evaluation in Angelman syndrome, focusing on molecular, neurobehavioral, and biomarker testing. Discover potential treatments and advances in research.
Stem Cell and Gene Therapy Platforms
Explore the latest advancements in stem cell and gene therapy platforms with Jan A. Nolta at the 2021 FAST Science Summit. Discover ongoing research, clinical trials, and future directions at UC Davis.
Roche Pharmaceuticals Angelman Syndrome Program Update to the FAST Community
“Explore the progress of Roche’s Angelman Syndrome Program, including updates on the TANGELO Phase 1 drug study and the FREESIAS observational study. Learn about our commitment to improving lives.”
Putting Patients at the Center
Explore Taysha Gene Therapies’ approach to developing treatments for rare neurological diseases, their partnership with UT Southwestern, and their commitment to patient-centered care.
Panel Discussion with Pharma
Get the latest updates on clinical trials for Angelman Syndrome from the 2021 FAST Science Summit. Learn about trial progress, patient selection, drug access, and future plans from leading pharma representatives.
Overview of the Therapeutic Landscape for Angelman Syndrome
Explore the therapeutic landscape for Angelman Syndrome with Allyson Berent, Chief Science Officer at FAST. Discover potential treatments, genetic insights, and the importance of research collaboration.